Compare Lustrum:Delta-Fly Pharma,Inc.:4598

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Delta-Fly Pharma,Inc. 4598 Medicals 東証グロース March 1, 2000 2018.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Delta-Fly Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Balance Sheet 2023年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2022年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2021年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2020年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
844down
(93.1%)down
1,268down
(95.8%)down
2,089up
(96.6%)up
1,944down
(89.9%)down
3,508
(98.3%)
Other Current AssetsHelp
(Percent)
22up
(2.4%)up
12down
(0.9%)down
27down
(1.2%)down
172up
(7.9%)up
24
(0.7%)
Tangible Fixed AssetsHelp
(Percent)
39down
(4.3%)up
40down
(3.0%)up
42down
(1.9%)down
43up
(2.0%)up
32
(0.9%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0down
(0.0%)down
0down
(0.0%)down
0
(0.0%)
Investments and OthersHelp
(Percent)
2down
(0.2%)down
4down
(0.3%)up
4up
(0.2%)up
3down
(0.2%)up
4
(0.1%)
Total AssetsHelp
(Percent)
907
(100%)
1,324
(100%)
2,161
(100%)
2,162
(100%)
3,567
(100%)
Total Current LiabilitiesHelp
(Percent)
116up
(12.7%)up
91up
(6.9%)up
82down
(3.8%)down
106up
(4.9%)up
50
(1.4%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
13
(0.4%)
Shareholder's EquityHelp
(Percent)
791down
(87.3%)down
1,233down
(93.1%)down
2,079up
(96.2%)up
2,056down
(95.1%)down
3,504
(98.2%)
Total LiabilitiesHelp
(Percent)
907
(100%)
1,324
(100%)
2,161
(100%)
2,162
(100%)
3,567
(100%)

Delta-Fly Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Profit and Loss Account 2023年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2022年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2021年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2020年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
0
(100%)
300
(100%)
300
(100%)
100
(100%)
0
(100%)
Total Sales
(Percent)
0
(100%)
300
(100%)
300
(100%)
100
(100%)
0
(100%)
Cost of SalesHelp
(Percent)

-

-

-

-
593
Other Costs and RevenueHelp 1,329up
1,267up
(422.4%)up
1,163down
(387.5%)down
1,656up
(1,655.8%)
81
Total CostsHelp 1,329 1,267 1,163 1,656 674
Net RevenueHelp
-

-

-

-
-593
Earnings Before TaxHelp -1,326down
-964down
(-321.4%)down
-859up
(-286.5%)up
-1,552down
(-1,552.2%)
-671
Net IncomeHelp -1,329down
-967down
(-322.4%)down
-863up
(-287.5%)up
-1,556down
(-1,555.8%)
-674
当期純利益 -1,329 -967 -863 -1,556 -674

Delta-Fly Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Cash Flow Statement 2023年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2022年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2021年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2020年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,303down
(-99.9%)up
-940down
(-100.0%)down
-727up
(-83.0%)up
-1,649down
(-99.1%)down
-585
(-17.6%)
Investing Cash Flow(ICF)Help
(Percent)

-
-0up
(0.0%)up
-1
(-0.1%)down
-1up
(0.0%)up
-13
(-0.4%)
Financing Cash FlowHelp
(Percent)
883up
(67.6%)up
120down
(12.7%)down
875up
(100.0%)up
100down
(6.0%)down
3,317
(99.7%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)

-
1up
(0.1%)up
-3up
(-0.4%)up
-15down
(-0.9%)down
9
(0.3%)
Net Increase and Decrease in Cash and Cash Equivalentsn -424up
(-32.5%)up
-820down
(-87.2%)down
145up
(16.5%)up
-1,565down
(-94.0%)down
2,727
(82.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Delta-Fly Pharma,Inc.

Company where related level is highHelp

Astellas Pharma Inc.
TMS Co.,Ltd.
EIKEN CHEMICAL CO.,LTD.
Kubota Pharmaceutical Holdings Co.,Ltd.
OncoTherapy Science,Inc.
MediciNova,Inc
WAKAMOTO PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
SanBio Company Limited